Cargando…
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
Ischemic stroke patients with active cancer are known to have poor clinical outcomes. However, the efficacy and safety of intravenous alteplase (IV t-PA) in this group are still unclear. In this study, we aimed to evaluate whether stroke patients with cancer had poor clinical outcomes after use of I...
Autores principales: | Nam, Ki-Woong, Kim, Chi Kyung, Kim, Tae Jung, An, Sang Joon, Oh, Kyungmi, Ko, Sang-Bae, Yoon, Byung-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474258/ https://www.ncbi.nlm.nih.gov/pubmed/28660209 http://dx.doi.org/10.1155/2017/4635829 |
Ejemplares similares
-
Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke
por: Nam, Ki-Woong, et al.
Publicado: (2017) -
Clinical Implications of Serial Glucose Measurements in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis
por: Kim, Joon-Tae, et al.
Publicado: (2018) -
Abdominal wall hemorrhage after intravenous thrombolysis for acute ischemic stroke
por: An, Se-A, et al.
Publicado: (2013) -
Long-term Prognosis of Patients Who Contraindicated for Intravenous Thrombolysis in Acute Ischemic Stroke
por: Lee, Bo-Yeon, et al.
Publicado: (2019) -
Comparative Effectiveness of Standard Care With IV Thrombolysis Versus Without IV Thrombolysis for Mild Ischemic Stroke
por: Choi, Jay Chol, et al.
Publicado: (2015)